By Kevin Madagan
Edgewater Capital Partners has announced an investment in CBCC Global Research.
CBCC, founded in 1984 and based in Bakersfield, California, is a clinical contract research organization with experience in designing and managing clinical trials in therapeutic areas including oncology, the central nervous system and ophthalmology.
Edgewater, founded in 1998 and based in Cleveland, is a private equity firm investing in the lower middle market. The firm is focused on the specialty industrials, life science, advanced materials and specialty chemicals sectors.
Terms of the investment were not disclosed.